EN
HI
Beryl Drugs Chart
Beryl Drugs Share Key Metrics
Volume
758.00
Market Cap
11.61 CR
LTQ@LTP
50@21.75
ATP
21.75
Var Margin
100 %
Circuit Range
21.75-24.03
Delivery %
100 %
Value
16486.50
ASM/GSM
No
Market Lot
1
Summary
Beryl Drugs share price stands at ₹21.75 at 5 May, 2026 | 15:25. The stock Beryl Drugs intraday movement has stayed between ₹21.75 and ₹22.60, while on a 52-week basis it has fluctuated from ₹15.92 to ₹30.00.
In terms of trading activity, Beryl Drugs has recorded a volume of 758 shares. The Beryl Drugs has a market cap of ₹5071700. The stock’s Average Traded Price (ATP) stands at ₹2175, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50, 2175.
The Beryl Drugs operates within a circuit range of ₹21.75-24.03 – ₹21.75-24.03, with a Value of ₹16486.50. The Delivery Percentage for the day is 100%. Additionally, Beryl Drugs currently falls under the No framework, and trades with a market lot size of 1.
Beryl Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
51.38
Sector P/B
3.49
Sec. Div. Yield
0.57
Beryl Drugs Resistance and Support
Pivot 22.21
Resistance
First Resistance
23.56
Second Resistance
24.24
Third Resistance
25.59
Support
First Support
21.53
Second Support
20.18
Third Support
19.5
Beryl Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-04-01 | Notice of EGM & Others |
| 2026-02-09 | Quarterly Results |
| 2026-01-03 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-09-02 | A.G.M. |
| 2025-08-07 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-08 | Quarterly Results |
Beryl Drugs News
About Beryl Drugs
NSE : 0
BSE : 524606
ISIN : INE415H01017
Beryl Drugs Management
| Name | Position |
|---|---|
| Sanjay Sethi | Managing Director |
| Sudhir Sethi | Chairman |
Beryl Drugs Similar Stocks
Bacil Pharma Ltd.
54.99
-0.69 (1.24%)
Ishita Drugs & Industries Ltd.
78.61
-0.39 (0.49%)
Emmessar Biotech & Nutrition Ltd.
26.20
0.70 (2.75%)
Cian Healthcare Ltd.
8.26
0.00 (0.00%)
Starsource Multitrade Ltd.
121.80
-1.20 (0.98%)
Sharma East India Hospitals & Medical Research Ltd
103.00
0.22 (0.21%)
Clinitech Laboratory Ltd.
41.25
0.00 (0.00%)
Norris Medicines Ltd.
14.75
0.64 (4.54%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Beryl Drugs FAQs
The Buying Price of Beryl Drugs share is 21.75 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Beryl Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beryl Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Beryl Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Beryl Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Beryl Drugs’s valuation compare Sector P/E, P/B which are 51.38 & 3.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Beryl Drugs is 11.61 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Beryl Drugs share price is 30.00 & 15.92. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Beryl Drugs belongs to the Healthcare sector.
